Navigation Links
Modified antibiotic may support fight cancer

According to recent experiments a molecule related to tetracycline can aid stop the spread of cancer cells. Researchers at the University of Iowa have been looking at a new drug called COL-3,// which is related to the well-known antibiotic tetracycline. In a series of experiments, they find that COL-3 acts upon the tissue surrounding a tumour, making that tumour less likely to spread throughout the body.

COL-3 appears to block some of the chemical signals that come from an existing tumour that otherwise encourage cancer cells' movement throughout the surrounding tissue. It may be that COL-3 would be useful in conjunction with conventional anti-cancer drugs which kill cancer cells. Further research will reveal whether this new approach is applicable to the long-term management of human cancer.


'"/>




Page: 1

Related medicine news :

1. Malaria To Be Tackled By Genetically Modified Mosquitoes
2. Stroke Rehabilitation Through Modified Video Games
3. Genetically Modified Cells Attack Tumors
4. TB can Be Eradicated in the U.S With Modified Guidelines: Study
5. Modified Ligament Surgery Improves Outcomes Players, Athletes
6. New antibiotic already developing resistance
7. Gene clue to antibiotics
8. Excessive use of antibiotics for sore throat
9. E. coli strains resistant to a common antibiotic
10. Cost-effective antibiotics for sinusitis treatment
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 Executive Forum, taking ... of the country’s top healthcare executives to share insights on transformational strategies to ... Forum is the provider-centric perspective, experience, expertise and strategy shared by the participants,” ...
(Date:2/10/2016)... MA (PRWEB) , ... February 10, 2016 , ... Gout ... switch, and brings pain that is often severe, with intense swelling and redness. It ... than eight million people, but older adults are the most susceptible, according to the ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA blood ... exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric ... in their patients. Research shows that the Goal Attainment Scale (GAS) captures 20% ... this challenge and learn more about the Goal Attainment Scale, Education Resources Inc. ...
(Date:2/10/2016)... ... February 10, 2016 , ... A ... Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's Bureau of ... , As the longest running and largest worker's compensation event in Ohio, ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... LONDON , February 10, 2016 ... 2016, which will be held at Victoria Park Plaza in ... host an informative seminar on technology and future advances for ... seminar, led by Lorna Graham , associate director of ... technology to keep up with new regulations and standards in ...
(Date:2/10/2016)... ATLANTA , Feb. 10, 2016  LexisNexis® ... and technology, today announced the launch of ... analytics solution that helps improve and optimize the ... evaluation of performance using severity-adjusted scores. By measuring ... a critical solution to deliver better outcomes, improve ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... biopharmaceutical company developing novel, clinical-stage therapies for sickle cell ... an underwritten public offering of 29,090,910 units at a ... unit consists of one share of the Company,s common ... the Company,s common stock at an exercise price of ...
Breaking Medicine Technology: